258 related articles for article (PubMed ID: 37604925)
1. Epigenetics behind tumor immunology: a mini review.
Musella M; Manduca N; Maccafeo E; Sistigu A
Oncogene; 2023 Sep; 42(39):2932-2938. PubMed ID: 37604925
[TBL] [Abstract][Full Text] [Related]
2. Antiviral Responses in Cancer: Boosting Antitumor Immunity Through Activation of Interferon Pathway in the Tumor Microenvironment.
Vitiello GAF; Ferreira WAS; Cordeiro de Lima VC; Medina TDS
Front Immunol; 2021; 12():782852. PubMed ID: 34925363
[TBL] [Abstract][Full Text] [Related]
3. The emerging role of epigenetic therapeutics in immuno-oncology.
Topper MJ; Vaz M; Marrone KA; Brahmer JR; Baylin SB
Nat Rev Clin Oncol; 2020 Feb; 17(2):75-90. PubMed ID: 31548600
[TBL] [Abstract][Full Text] [Related]
4. Epigenetics and immunotherapy: The current state of play.
Dunn J; Rao S
Mol Immunol; 2017 Jul; 87():227-239. PubMed ID: 28511092
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities.
Tien FM; Lu HH; Lin SY; Tsai HC
J Biomed Sci; 2023 Jan; 30(1):3. PubMed ID: 36627707
[TBL] [Abstract][Full Text] [Related]
6. Is there a Role for Epigenetic Enhancement of Immunomodulatory Approaches to Cancer Treatment?
Flower KJ; Ghaem-Maghami S; Brown R
Curr Cancer Drug Targets; 2018; 18(1):5-15. PubMed ID: 28176650
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets.
Yang J; Xu J; Wang W; Zhang B; Yu X; Shi S
Signal Transduct Target Ther; 2023 May; 8(1):210. PubMed ID: 37217462
[TBL] [Abstract][Full Text] [Related]
8. Type I interferons and dendritic cells in cancer immunotherapy.
Sprooten J; Agostinis P; Garg AD
Int Rev Cell Mol Biol; 2019; 348():217-262. PubMed ID: 31810554
[TBL] [Abstract][Full Text] [Related]
9. A New Trend in Cancer Treatment: The Combination of Epigenetics and Immunotherapy.
Liu Z; Ren Y; Weng S; Xu H; Li L; Han X
Front Immunol; 2022; 13():809761. PubMed ID: 35140720
[TBL] [Abstract][Full Text] [Related]
10. Epigenetics in modulating immune functions of stromal and immune cells in the tumor microenvironment.
Pan X; Zheng L
Cell Mol Immunol; 2020 Sep; 17(9):940-953. PubMed ID: 32699350
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic Modifiers: Anti-Neoplastic Drugs With Immunomodulating Potential.
Maes K; Mondino A; Lasarte JJ; Agirre X; Vanderkerken K; Prosper F; Breckpot K
Front Immunol; 2021; 12():652160. PubMed ID: 33859645
[TBL] [Abstract][Full Text] [Related]
12. Overcoming Resistance to Combination Radiation-Immunotherapy: A Focus on Contributing Pathways Within the Tumor Microenvironment.
Darragh LB; Oweida AJ; Karam SD
Front Immunol; 2018; 9():3154. PubMed ID: 30766539
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic modifiers in immunotherapy: a focus on checkpoint inhibitors.
Terranova-Barberio M; Thomas S; Munster PN
Immunotherapy; 2016 Jun; 8(6):705-19. PubMed ID: 27197539
[TBL] [Abstract][Full Text] [Related]
14. EZH2, a prominent orchestrator of genetic and epigenetic regulation of solid tumor microenvironment and immunotherapy.
Sun S; Yu F; Xu D; Zheng H; Li M
Biochim Biophys Acta Rev Cancer; 2022 Mar; 1877(2):188700. PubMed ID: 35217116
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy.
Kawakubo K; Castillo CF; Liss AS
J Gastroenterol; 2022 Nov; 57(11):819-826. PubMed ID: 36048239
[TBL] [Abstract][Full Text] [Related]
16. Genetic dysregulation of immunologic and oncogenic signaling pathways associated with tumor-intrinsic immune resistance: a molecular basis for combination targeted therapy-immunotherapy for cancer.
Hargadon KM
Cell Mol Life Sci; 2023 Jan; 80(2):40. PubMed ID: 36629955
[TBL] [Abstract][Full Text] [Related]
17. Cancer Epigenetics, Tumor Immunity, and Immunotherapy.
Cao J; Yan Q
Trends Cancer; 2020 Jul; 6(7):580-592. PubMed ID: 32610068
[TBL] [Abstract][Full Text] [Related]
18. The complex role of EZH2 in the tumor microenvironment: opportunities and challenges for immunotherapy combinations.
Qiu J; Sharma S; Rollins RA; Paul TA
Future Med Chem; 2020 Aug; 12(15):1415-1430. PubMed ID: 32723083
[TBL] [Abstract][Full Text] [Related]
19. H3K4 trimethylation regulates cancer immunity: a promising therapeutic target in combination with immunotherapy.
Xiao C; Fan T; Zheng Y; Tian H; Deng Z; Liu J; Li C; He J
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37553181
[TBL] [Abstract][Full Text] [Related]
20. Size-optimized nuclear-targeting phototherapy enhances the type I interferon response for "cold" tumor immunotherapy.
Zhang X; Yi C; Zhang L; Zhu X; He Y; Lu H; Li Y; Tang Y; Zhao W; Chen G; Wang C; Huang S; Ouyang G; Yu D
Acta Biomater; 2023 Mar; 159():338-352. PubMed ID: 36669551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
